WhiteOak Capital Pharma and Healthcare Fund - Regular Plan - Growth
Investment Objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Fund Mandate
TRUSTMF Small Cap Fund - Growth - Direct Plan and 4 more peers in this category.
Build comparisonWhiteOak Capital MF Latest News
Category avg is the average return of every scheme in this fund's SEBI class (Equity - Sectoral Fund - Pharma & Health Care) over the same period. Returns up to 1 year are absolute; returns beyond 1 year are annualised (CAGR). This is Accord's own stated convention for equity-oriented schemes.
A measure of how much a fund's returns swing up and down over time. Higher means a bumpier ride — more volatility — even if the average return ends up the same as a steadier fund.
How sensitive a fund is to overall market moves. A beta of 1 means it roughly moves in line with the market; below 1 means smaller swings than the market; above 1 means bigger swings in both directions.
How much extra return a fund earned for every unit of risk (volatility) it took on, compared to a safe, risk-free investment. Higher means better risk-adjusted performance — not just higher returns, but smarter ones.
The extra return a fund generated above what its benchmark index would predict, given the risk it took. Positive alpha suggests the fund manager added genuine value beyond just tracking the market.
Similar to the Sharpe Ratio, but only counts downside volatility (the bad kind) rather than penalizing a fund for volatile-but-positive swings. Higher means better returns per unit of "harmful" risk.
The single worst peak-to-trough fall a fund has experienced over a given period — the deepest "how much would I have lost if I'd bought at the top and sold at the bottom" scenario.
This is an equity-oriented fund. Under rules effective since Budget 2024 (23 July 2024):
Short-Term Capital Gains (held ≤ 12 months): taxed at a flat 20%.
Long-Term Capital Gains (held > 12 months): taxed at 12.5% on gains above ₹1.25 lakh in a financial year, with no indexation benefit.
General information only, not tax advice, actual liability depends on your overall income and applicable law at the time of redemption. Consult a tax advisor for your specific situation.